Brian C. Broderick’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,744
Closed -$710K 94
2017
Q3
$710K Hold
9,744
0.26% 65
2017
Q2
$722K Sell
9,744
-166
-2% -$12.3K 0.27% 65
2017
Q1
$725K Sell
9,910
-514
-5% -$36K 0.3% 60
2016
Q4
$681K Sell
10,424
-260
-2% -$17.8K 0.3% 62
2016
Q3
$792K Sell
10,684
-625
-6% -$46.2K 0.34% 56
2016
Q2
$827K Buy
11,309
+200
+2% +$14.2K 0.35% 58
2016
Q1
$784K Buy
11,109
+5,371
+94% +$357K 0.34% 60
2015
Q4
$383K Buy
+5,738
New +$382K 0.17% 78

Other funds holding CL

Brian C. Broderick's CL Position: Q4 2017 in Review

Brian C. Broderick sold out of Colgate-Palmolive (CL) in Q4 2017, closing a stake of 9,744 shares — an estimated $710K sold.

Brian C. Broderick first reported a position in CL in Q4 2015 and held it in 8 quarters. The position peaked at $827K in Q2 2016. 1,474 funds tracked by Wall St. Rank hold CL as of Q4 2017.

  • Brian C. Broderick reported no remaining Colgate-Palmolive position as of Q4 2017 after selling out during the quarter.
  • Brian C. Broderick sold 9,744 Colgate-Palmolive shares in Q4 2017, an estimated $710K.
  • Brian C. Broderick first reported a position in Colgate-Palmolive in Q4 2015 and held it in 8 quarters.
  • Brian C. Broderick's Colgate-Palmolive position peaked at $827K in Q2 2016.
  • 1,474 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2017.

Based on Brian C. Broderick's 13F filing for Q4 2017, filed 2 Feb 2018.